ING Groep NV Purchases New Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

ING Groep NV purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 867,302 shares of the company’s stock, valued at approximately $63,226,000. ING Groep NV owned approximately 0.68% of Henry Schein as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of HSIC. Cromwell Holdings LLC raised its stake in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new position in Henry Schein during the 2nd quarter worth $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein in the 2nd quarter valued at $37,000. Blue Trust Inc. increased its stake in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after buying an additional 475 shares during the period. Finally, Farther Finance Advisors LLC raised its position in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 1.4 %

NASDAQ HSIC traded down $0.97 during trading hours on Thursday, reaching $66.77. 368,756 shares of the company’s stock were exchanged, compared to its average volume of 1,347,771. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $8.32 billion, a price-to-earnings ratio of 27.88, a price-to-earnings-growth ratio of 1.93 and a beta of 0.87. The company’s 50-day moving average is $70.37 and its two-hundred day moving average is $69.62. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.32 earnings per share. On average, analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the subject of a number of research reports. JPMorgan Chase & Co. lowered their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. UBS Group lowered their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Robert W. Baird decreased their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Hold” and a consensus target price of $77.50.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.